In a second parallel approach to identify epigenetic regulators interacting with activator E2fs in TKO HCC, we performed mass spectrometry (MS) in the pull-down fraction of E2f1 and E2f3 in TKO HCC cells (Fig. 3e,f). The gene discussed is E2F3; the disease is hepatocellular carcinoma.